Access DX Agrees to $36.4 Million Settlement Over Alleged Genetic Testing Kickback Scheme
For two years, according to federal prosecutors, the business model at Access DX Laboratory rested on finding more patients, ordering more genetic tests, and billing the government. The methods, the Justice Department alleges, included paying marketers for referrals, compensating telemedicine providers for fraudulent physician orders, breaking genetic tests into separately billable components, and sending Medicare and Medicaid the bill for testing that was not medically necessary. That alleged scheme has now produced a $36.4 million resolution.